Study for predictors of response to infliximab therapy for ulcerative colitis
Not Applicable
- Conditions
- lcerative colitis
- Registration Number
- JPRN-UMIN000007256
- Lead Sponsor
- Kanagawa Crohn Disease Treatment Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patient whose age below 16 years old 2)Patients who cannot been kept in the treatment with infliximab (Patients with serious infection, active tuberculosis, history of allergy to ingredients of infliximab or to proteins derived from mouse, demyelinating diseases and its past history, congestive heart failure) 3)Patients who are pregnant 4)Patients who are inadequate to enter this trial due to the other reasons by physician's judgments
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Remission rate at week 10 and 54 (Lichitiger index)
- Secondary Outcome Measures
Name Time Method